• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞质中的钙调蛋白激酶IIδ-B会阻碍心力衰竭时的心肌恢复。

Cytoplasmic CaMKIIδ-B prevents myocardial recovery in heart failure.

作者信息

Martin Thomas G, Hunt Dakota R, Ebmeier Christopher C, Dhand Abhishek P, Alamana Christina, Cleveland Joseph C, Graw Sharon L, Bruner Sarah, Bristow Michael R, Mestroni Luisa, Taylor Matthew R G, Burdick Jason A, Ambardekar Amrut V, Buttrick Peter M, Leinwand Leslie A

机构信息

Department of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, CO, 80303, USA.

BioFrontiers Institute, University of Colorado Boulder, Boulder CO, 80303, USA.

出版信息

bioRxiv. 2025 May 21:2025.05.16.654509. doi: 10.1101/2025.05.16.654509.

DOI:10.1101/2025.05.16.654509
PMID:40475607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12139807/
Abstract

Restoration of cardiac function in patients with advanced heart failure is rare, and the molecular processes that regulate recovery are unknown. To identify potential mechanisms, we studied paired myocardial samples before and after left ventricular assist device therapy, where significant cardiac functional recovery occurred in ~25% of patients. We found that expression of the nuclear B isoform of Ca/calmodulin-dependent protein kinase IIδ (CaMKIIδ-B) inversely correlated with recovery. Furthermore, increased phosphorylation near the CaMKIIδ-B nuclear localization signal in non-responders prevented its auto-activation dependent nuclear translocation. Expression of a cytoplasm-restricted CaMKIIδ-B in cardiomyocytes dramatically remodeled the phospho-proteome and impaired contractility, while a nuclear-competent version did not. Modulating CaMKIIδ subcellular localization may thus represent a therapeutic strategy for advanced heart failure.

摘要

晚期心力衰竭患者心脏功能的恢复很少见,且调节恢复的分子过程尚不清楚。为了确定潜在机制,我们研究了左心室辅助装置治疗前后的配对心肌样本,约25%的患者出现了显著的心脏功能恢复。我们发现,钙/钙调蛋白依赖性蛋白激酶IIδ(CaMKIIδ)的核B亚型(CaMKIIδ-B)的表达与恢复呈负相关。此外,无反应者中CaMKIIδ-B核定位信号附近磷酸化增加,阻止了其依赖自身激活的核转位。心肌细胞中细胞质限制型CaMKIIδ-B的表达显著重塑了磷酸化蛋白质组并损害了收缩性,而具有核活性的版本则没有。因此,调节CaMKIIδ的亚细胞定位可能代表一种晚期心力衰竭的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef35/12139807/2800687fadb9/nihpp-2025.05.16.654509v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef35/12139807/95782689bcd8/nihpp-2025.05.16.654509v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef35/12139807/9d91ec5dcf8e/nihpp-2025.05.16.654509v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef35/12139807/e59cb6fdd54c/nihpp-2025.05.16.654509v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef35/12139807/170cae4076b1/nihpp-2025.05.16.654509v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef35/12139807/2800687fadb9/nihpp-2025.05.16.654509v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef35/12139807/95782689bcd8/nihpp-2025.05.16.654509v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef35/12139807/9d91ec5dcf8e/nihpp-2025.05.16.654509v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef35/12139807/e59cb6fdd54c/nihpp-2025.05.16.654509v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef35/12139807/170cae4076b1/nihpp-2025.05.16.654509v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef35/12139807/2800687fadb9/nihpp-2025.05.16.654509v1-f0005.jpg

相似文献

1
Cytoplasmic CaMKIIδ-B prevents myocardial recovery in heart failure.细胞质中的钙调蛋白激酶IIδ-B会阻碍心力衰竭时的心肌恢复。
bioRxiv. 2025 May 21:2025.05.16.654509. doi: 10.1101/2025.05.16.654509.
2
Elimination of CaMKIIδ Autophosphorylation by CRISPR-Cas9 Base Editing Improves Survival and Cardiac Function in Heart Failure in Mice.CRISPR-Cas9 碱基编辑消除 CaMKIIδ 自磷酸化可改善心力衰竭小鼠的生存和心脏功能。
Circulation. 2023 Nov 7;148(19):1490-1504. doi: 10.1161/CIRCULATIONAHA.123.065117. Epub 2023 Sep 15.
3
Involvement of the dual-specificity tyrosine phosphorylation-regulated kinase 1A-alternative splicing factor-calcium/calmodulin-dependent protein kinase IIδ signaling pathway in myocardial infarction-induced heart failure of rats.双特异性酪氨酸磷酸化调节激酶 1A-剪接因子-钙/钙调蛋白依赖性蛋白激酶 IIδ 信号通路在大鼠心肌梗死后心力衰竭中的作用。
J Card Fail. 2015 Sep;21(9):751-60. doi: 10.1016/j.cardfail.2015.05.015. Epub 2015 Jun 9.
4
Structural and functional cardiac profile after prolonged duration of mechanical unloading: potential implications for myocardial recovery.机械卸载时间延长后的心脏结构和功能特征:对心肌恢复的潜在影响。
Am J Physiol Heart Circ Physiol. 2018 Nov 1;315(5):H1463-H1476. doi: 10.1152/ajpheart.00187.2018. Epub 2018 Aug 24.
5
CaMKIIdelta isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses.钙/钙调蛋白依赖性蛋白激酶IIdelta亚型对钙处理有不同影响,但对组蛋白去乙酰化酶/肌细胞增强因子2转录反应的调节作用相似。
J Biol Chem. 2007 Nov 30;282(48):35078-87. doi: 10.1074/jbc.M707083200. Epub 2007 Oct 8.
6
Location matters: clarifying the concept of nuclear and cytosolic CaMKII subtypes.位置很重要:澄清核和胞质 CaMKII 亚型的概念。
Circ Res. 2011 Dec 9;109(12):1354-62. doi: 10.1161/CIRCRESAHA.111.248401. Epub 2011 Oct 13.
7
Ca2+/Calmodulin-dependent protein kinase II δ mediates myocardial ischemia/reperfusion injury through nuclear factor-κB.钙/钙调蛋白依赖性蛋白激酶 II δ 通过核因子-κB 介导心肌缺血/再灌注损伤。
Circ Res. 2013 Mar 15;112(6):935-44. doi: 10.1161/CIRCRESAHA.112.276915. Epub 2013 Feb 6.
8
Effects on recovery during acidosis in cardiac myocytes overexpressing CaMKII.对过表达CaMKII的心肌细胞酸中毒期间恢复的影响。
J Mol Cell Cardiol. 2007 Dec;43(6):696-709. doi: 10.1016/j.yjmcc.2007.09.008. Epub 2007 Oct 22.
9
Cardiomyocyte calcium and calcium/calmodulin-dependent protein kinase II: friends or foes?心肌细胞钙与钙/钙调蛋白依赖性蛋白激酶II:是友还是敌?
Recent Prog Horm Res. 2004;59:141-68. doi: 10.1210/rp.59.1.141.
10
Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca/Calmodulin-Dependent Protein Kinase II δ Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling.钙/钙调蛋白依赖性蛋白激酶 II δ 信号通路通过心肌细胞对压力超负荷的反应引发的炎症和 NLRP3 炎性小体激活对于心脏不良重构是必需的。
Circulation. 2018 Nov 27;138(22):2530-2544. doi: 10.1161/CIRCULATIONAHA.118.034621.

本文引用的文献

1
Contemporary pharmacological treatment and management of heart failure.当代心力衰竭的药物治疗与管理
Nat Rev Cardiol. 2024 Aug;21(8):545-555. doi: 10.1038/s41569-024-00997-0. Epub 2024 Mar 26.
2
Advancements in Heart Failure Management: A Comprehensive Narrative Review of Emerging Therapies.心力衰竭管理的进展:新兴疗法的全面叙述性综述
Cureus. 2023 Oct 4;15(10):e46486. doi: 10.7759/cureus.46486. eCollection 2023 Oct.
3
CRISPR-Cas9 base editing of pathogenic CaMKIIδ improves cardiac function in a humanized mouse model.
CRISPR-Cas9 碱基编辑纠正致病性 CaMKIIδ 改善人源化小鼠模型心功能
J Clin Invest. 2024 Jan 2;134(1):e175164. doi: 10.1172/JCI175164.
4
Assessment of Autophagy Markers Suggests Increased Activity Following LVAD Therapy.自噬标志物评估表明左心室辅助装置治疗后活性增加。
JACC Basic Transl Sci. 2023 Aug 23;8(9):1043-1056. doi: 10.1016/j.jacbts.2023.05.015. eCollection 2023 Sep.
5
Elimination of CaMKIIδ Autophosphorylation by CRISPR-Cas9 Base Editing Improves Survival and Cardiac Function in Heart Failure in Mice.CRISPR-Cas9 碱基编辑消除 CaMKIIδ 自磷酸化可改善心力衰竭小鼠的生存和心脏功能。
Circulation. 2023 Nov 7;148(19):1490-1504. doi: 10.1161/CIRCULATIONAHA.123.065117. Epub 2023 Sep 15.
6
Defining cardiac functional recovery in end-stage heart failure at single-cell resolution.在单细胞分辨率下定义终末期心力衰竭中的心脏功能恢复。
Nat Cardiovasc Res. 2023 Apr;2(4):399-416. doi: 10.1038/s44161-023-00260-8. Epub 2023 Apr 6.
7
Myocardial Recovery.心肌恢复
Diagnostics (Basel). 2023 Apr 21;13(8):1504. doi: 10.3390/diagnostics13081504.
8
Burden, Trends, and Inequalities of Heart Failure Globally, 1990 to 2019: A Secondary Analysis Based on the Global Burden of Disease 2019 Study.全球心力衰竭负担、趋势和不平等状况:基于 2019 年全球疾病负担研究的二次分析。
J Am Heart Assoc. 2023 Mar 21;12(6):e027852. doi: 10.1161/JAHA.122.027852. Epub 2023 Mar 9.
9
Cardiac splicing as a diagnostic and therapeutic target.心脏剪接作为诊断和治疗靶点。
Nat Rev Cardiol. 2023 Aug;20(8):517-530. doi: 10.1038/s41569-022-00828-0. Epub 2023 Jan 18.
10
Ablation of CaMKIIδ oxidation by CRISPR-Cas9 base editing as a therapy for cardiac disease.利用 CRISPR-Cas9 碱基编辑技术消除 CaMKIIδ 的氧化修饰作为治疗心脏病的一种方法。
Science. 2023 Jan 13;379(6628):179-185. doi: 10.1126/science.ade1105. Epub 2023 Jan 12.